Immix Biopharma
IMMX
IMMX
23 hedge funds and large institutions have $4.68M invested in Immix Biopharma in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
23
Holders Change
+1
Holders Change %
+4.55%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
5
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$88.2K |
| 2 |
BlackRock
New York
|
+$58.9K |
| 3 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$51.8K |
| 4 |
TW
TritonPoint Wealth
Chevy Chase,
Maryland
|
+$50.8K |
| 5 |
VF
Virtu Financial
New York
|
+$37K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FIA
26
FNY Investment Advisers
New York
| – | -$18K | -11,250 | Closed |
|
27
JPMorgan Chase & Co
New York
| – | -$59 | -35 | Closed |
|